Literature DB >> 20636651

Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney.

Joanne Bryant1, Libby Topp, Max Hopwood, Jenny Iversen, Carla Treloar, Lisa Maher.   

Abstract

INTRODUCTION AND AIMS: The comprehensive needle and syringe distribution system in New South Wales is partly based on the premise that different points of access to injecting equipment may attract different groups of injecting drug users. This paper examines patterns of equipment acquisition and risk for blood-borne virus transmission among injecting drug users who use pharmacies and needle and syringe programs (NSP) in south-east Sydney. DESIGN AND METHODS: Clients obtaining injecting equipment from four NSP (n = 147) and eight pharmacies (n = 227) in 2006 voluntarily completed a self-administered questionnaire. Respondents were grouped into three categories based on their needle and syringe acquisition patterns: exclusive use of NSP, exclusive use of pharmacies and use of both.
RESULTS: Although it was common for respondents to report using both pharmacies and NSP to obtain needles and syringes (57%), a proportion reported exclusive use of pharmacies (17%) and NSP (14%). Exclusive pharmacy users were more likely to have never received treatment for their drug use and the least likely to have had a recent test for hepatitis C. Compared with respondents who exclusively used NSP, respondents who exclusively used pharmacies were more likely to report receptive sharing of injecting equipment (adjusted odds ratio 5.9, 95% confidence interval 2.02-17.14), as were respondents who reported using both sources (adjusted odds ratio 5.8, 95% confidence interval 2.35-14.40). DISCUSSION AND
CONCLUSIONS: The high prevalence of receptive equipment sharing among pharmacy clients indicates a need to improve access to needles and syringes and ancillary equipment, possibly by including ancillary equipment at no cost in existing pre-packaged pharmacy products.

Entities:  

Mesh:

Year:  2010        PMID: 20636651     DOI: 10.1111/j.1465-3362.2009.00154.x

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  6 in total

1.  Reduction in HCV incidence among injection drug users attending needle and syringe programs in Australia: a linkage study.

Authors:  Jenny Iversen; Handan Wand; Libby Topp; John Kaldor; Lisa Maher
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

2.  Setting foot in private spaces: extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines, a mixed methods study.

Authors:  Heidi Coupland; Charles Henderson; Janice Pritchard-Jones; Shih-Chi Kao; Sinead Sheils; Regina Nagy; Martin O'Donnell; Paul S Haber; Carolyn A Day
Journal:  Harm Reduct J       Date:  2022-05-28

3.  Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.

Authors:  Zaino Petersen; Bronwyn Myers; Marie-Claire van Hout; Andreas Plüddemann; Charles Parry
Journal:  Harm Reduct J       Date:  2013-08-19

4.  Needle acquisition patterns, network risk and social capital among rural PWID in Puerto Rico.

Authors:  Ian Duncan; Patrick Habecker; Roberto Abadie; Ric Curtis; Bilal Khan; Kirk Dombrowski
Journal:  Harm Reduct J       Date:  2017-10-18

Review 5.  Scoping out the literature on mobile needle and syringe programs-review of service delivery and client characteristics, operation, utilization, referrals, and impact.

Authors:  Carol Strike; Miroslav Miskovic
Journal:  Harm Reduct J       Date:  2018-02-08

6.  Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.

Authors:  Meghan D Morris; Jennifer Evans; Martha Montgomery; Michelle Yu; Alya Briceno; Kimberly Page; Judith A Hahn
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.